Cargando…
Chances and risks of sodium-glucose cotransporter 2 inhibitors in solid organ transplantation: A review of literatures
Solid organ transplantation offers life-saving treatment for patients with end-organ dysfunction. Patient survival and quality of life have improved over the past few decades as a result of pharmacological development, expansion of the donor pool, technological advances and standardization of practi...
Autores principales: | Schwarzenbach, Marlene, Bernhard, Flavia Elena, Czerlau, Cecilia, Sidler, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290999/ https://www.ncbi.nlm.nih.gov/pubmed/34316450 http://dx.doi.org/10.5500/wjt.v11.i7.254 |
Ejemplares similares
-
Sodium-glucose cotransporter-2 inhibitor use in kidney transplant recipients
por: Ramakrishnan, Pavithra, et al.
Publicado: (2023) -
Sodium glucose cotransporter 2 inhibitors: New horizon of the heart failure pharmacotherapy
por: Naito, Ryo, et al.
Publicado: (2021) -
Solid organ transplantations and COVID-19 disease
por: Yılmaz, Emine Aylin, et al.
Publicado: (2021) -
Kidney disease in non-kidney solid organ transplantation
por: Swanson, Kurtis J
Publicado: (2022) -
Multi-Organ Protective Effects of Sodium Glucose Cotransporter 2 Inhibitors
por: Yanai, Hidekatsu, et al.
Publicado: (2021)